Exponent, Inc. (NASDAQ:EXPO - Get Free Report) reached a new 52-week low during trading on Monday . The company traded as low as $63.81 and last traded at $68.55, with a volume of 949090 shares changing hands. The stock had previously closed at $68.96.
Exponent Trading Down 0.0%
The stock has a market capitalization of $3.62 billion, a price-to-earnings ratio of 35.62 and a beta of 0.89. The company's 50 day moving average is $74.27 and its 200 day moving average is $79.74.
Exponent (NASDAQ:EXPO - Get Free Report) last posted its earnings results on Thursday, July 31st. The business services provider reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.04. The business had revenue of $132.87 million during the quarter, compared to the consensus estimate of $130.82 million. Exponent had a return on equity of 24.19% and a net margin of 18.35%. The business's quarterly revenue was up 7.3% on a year-over-year basis. During the same period in the previous year, the business earned $0.57 EPS. Analysts anticipate that Exponent, Inc. will post 1.98 EPS for the current fiscal year.
Exponent Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, September 19th. Stockholders of record on Friday, September 5th will be issued a $0.30 dividend. The ex-dividend date of this dividend is Friday, September 5th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.7%. Exponent's payout ratio is presently 60.00%.
Insider Activity
In other Exponent news, VP Joseph Rakow sold 1,573 shares of the company's stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $77.72, for a total transaction of $122,253.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP John Pye sold 2,000 shares of Exponent stock in a transaction dated Friday, May 23rd. The shares were sold at an average price of $76.32, for a total transaction of $152,640.00. Following the completion of the sale, the vice president directly owned 29,204 shares in the company, valued at approximately $2,228,849.28. The trade was a 6.41% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 6,267 shares of company stock valued at $489,120. Company insiders own 1.60% of the company's stock.
Institutional Trading of Exponent
A number of institutional investors have recently modified their holdings of the business. Brooklyn Investment Group grew its stake in shares of Exponent by 10,200.0% during the 1st quarter. Brooklyn Investment Group now owns 309 shares of the business services provider's stock worth $25,000 after purchasing an additional 306 shares during the period. Whipplewood Advisors LLC grew its position in Exponent by 5,333.3% during the first quarter. Whipplewood Advisors LLC now owns 326 shares of the business services provider's stock worth $26,000 after buying an additional 320 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. purchased a new position in Exponent in the second quarter valued at about $34,000. UMB Bank n.a. lifted its position in shares of Exponent by 859.1% during the 1st quarter. UMB Bank n.a. now owns 633 shares of the business services provider's stock valued at $51,000 after acquiring an additional 567 shares during the period. Finally, Johnson Financial Group Inc. acquired a new stake in shares of Exponent in the 4th quarter worth approximately $59,000. 92.37% of the stock is currently owned by hedge funds and other institutional investors.
About Exponent
(
Get Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
See Also
Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.